PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

Jaguar Health, Inc.

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from Jaguar Health, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.

What stands out

  • Shareholder Slice Ratio: Share count rose 474,493% in 3 years, so each share's slice of the company became smaller. Bigger rise in share count than almost all Healthcare companies in United States.
  • Cash Cushion Ratio: Debt, after subtracting cash, is 10.2 times its market value (net debt). Lower than almost all Healthcare companies in United States.

Where $100 of sales goes

$492Operating costs$0.6Interest$464Net loss

Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.

Cash quality

Profit Cash Ratio

—

Loss-making or profit too small

Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.

Self-Funding Ratio

—

Data incomplete

Cash Locked Ratio

$13

For every $100 of sales, $13 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $26 tied up three years earlier.

Less money tied up than 73% of Healthcare companies in United States.

Growth quality

Steadiness Ratio

1/3 · 2/3

Sales grew in 1 of the last 3 years; profit grew in 2 of 3.

Steadier than 50% of Healthcare companies in United States.

Growth Efficiency Ratio

—

Sales barely changed

Sales changed by -4% in 3 years, too little to measure extra profit per extra sales.

Asset Productivity Ratio

-4% / -19%

In 3 years sales changed by -4% while total assets changed by -19%. Sales grew faster than assets.

Balance-sheet strength

Debt Due Cover Ratio

-0.9×

Operating cash was negative last year, while some debt falls due within a year.

Higher than 67% of Healthcare companies in United States.

Cash Cushion Ratio

10.2× debt

Debt, after subtracting cash, is 10.2 times its market value (net debt).

Lower than almost all Healthcare companies in United States.

Tangible Assets Ratio

58%

Of every $100 the company owns, $58 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.

Less tangible than 70% of Healthcare companies in United States.

Tangible Net Worth Ratio

—

Data incomplete

Shareholders

Shareholder Slice Ratio

+474,493%

Share count rose 474,493% in 3 years, so each share's slice of the company became smaller.

Bigger rise in share count than almost all Healthcare companies in United States.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (13)

Jaguar Health, Inc. made a loss over the last year. Jaguar Health, Inc. owes $0.86 for every $1 it owns. Jaguar Health, Inc. made a loss in each of the last two years.

Compared with Healthcare companies in United States · latest annual results Dec 2025.

P/E ratio

Loss

Jaguar Health, Inc. made a loss over the last year, so its P/E ratio is not meaningful.

P/B ratio

0.63

The share price is 0.63 times Jaguar Health, Inc.'s book value per share, lower than 88% of Healthcare companies in United States.

Market cap

$4 M

The total market value of all of Jaguar Health, Inc.'s shares at today's price (share price × number of shares), smaller than 94% of Healthcare companies in United States. PosiCap size class: Nano Cap.

Net worth (book value)

$7 M

What Jaguar Health, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).

Book value per share

$3.40

Net worth divided by the number of shares. The share price of $2.15 is 0.6 times this, which is the P/B above.

Return on equity (ROE)

-548.8%

Jaguar Health, Inc. lost 548.8% of its shareholders' money over the last year, lower than 94% of Healthcare companies in United States.

Owes vs Owns

0.86×

Jaguar Health, Inc. owes $0.86 for every $1 it owns (high), higher than 81% of Healthcare companies in United States.

Dividend yield

None

Jaguar Health, Inc. does not currently pay a dividend.

Revenue growth

-2%

Revenue fell 2% in the year to Dec 2025, and shrank 1% a year on average over 3 years.

Profit growth

Loss

Jaguar Health, Inc. made a loss in each of the last two years.

Profit margin

-464.2%

Jaguar Health, Inc. lost $464 for every $100 of revenue.

Interest cover

Not covered

Jaguar Health, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.

Cash vs debt

Net debt

Jaguar Health, Inc. had $43 M more debt than cash (net debt) at Dec 2025.

Questions

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For Jaguar Health, Inc.: $4 M ÷ $7 M (30 Jun 2026) = 0.6.

What is Jaguar Health, Inc.'s return on equity?

Jaguar Health, Inc. lost 548.8% of its shareholders' money over the last year, lower than 94% of Healthcare companies in United States.

How much does Jaguar Health, Inc. owe compared with what it owns?

Jaguar Health, Inc. owes $0.86 for every $1 it owns (high), higher than 81% of Healthcare companies in United States.

Does Jaguar Health, Inc. pay a dividend?

No. Jaguar Health, Inc. does not currently pay a dividend.

Is Jaguar Health, Inc.'s revenue growing?

Revenue fell 2% in the year to Dec 2025, and shrank 1% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.